These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 30100517)

  • 1. Targeting Mitochondrial Metabolism in Neuroinflammation: Towards a Therapy for Progressive Multiple Sclerosis.
    Peruzzotti-Jametti L; Pluchino S
    Trends Mol Med; 2018 Oct; 24(10):838-855. PubMed ID: 30100517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial complex I activity in microglia sustains neuroinflammation.
    Peruzzotti-Jametti L; Willis CM; Krzak G; Hamel R; Pirvan L; Ionescu RB; Reisz JA; Prag HA; Garcia-Segura ME; Wu V; Xiang Y; Barlas B; Casey AM; van den Bosch AMR; Nicaise AM; Roth L; Bates GR; Huang H; Prasad P; Vincent AE; Frezza C; Viscomi C; Balmus G; Takats Z; Marioni JC; D'Alessandro A; Murphy MP; Mohorianu I; Pluchino S
    Nature; 2024 Apr; 628(8006):195-203. PubMed ID: 38480879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity.
    Thompson KK; Tsirka SE
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate and adaptive immune responses in neurodegeneration and repair.
    Amor S; Woodroofe MN
    Immunology; 2014 Mar; 141(3):287-91. PubMed ID: 23758741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting innate immunity for neurodegenerative disorders of the central nervous system.
    Andreasson KI; Bachstetter AD; Colonna M; Ginhoux F; Holmes C; Lamb B; Landreth G; Lee DC; Low D; Lynch MA; Monsonego A; O'Banion MK; Pekny M; Puschmann T; Russek-Blum N; Sandusky LA; Selenica ML; Takata K; Teeling J; Town T; Van Eldik LJ
    J Neurochem; 2016 Sep; 138(5):653-93. PubMed ID: 27248001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis.
    Pluchino S; Smith JA; Peruzzotti-Jametti L
    Trends Mol Med; 2020 Oct; 26(10):898-912. PubMed ID: 32448751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of microRNA in microglia-mediated immune response.
    Guedes J; Cardoso AL; Pedroso de Lima MC
    Clin Dev Immunol; 2013; 2013():186872. PubMed ID: 23762086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia-Specific Metabolic Changes in Neurodegeneration.
    Aldana BI
    J Mol Biol; 2019 Apr; 431(9):1830-1842. PubMed ID: 30878483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression.
    Fraussen J; de Bock L; Somers V
    Autoimmun Rev; 2016 Sep; 15(9):896-9. PubMed ID: 27396817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive multiple sclerosis.
    Bradl M; Lassmann H
    Semin Immunopathol; 2009 Nov; 31(4):455-65. PubMed ID: 19730864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria and the link between neuroinflammation and neurodegeneration.
    Di Filippo M; Chiasserini D; Tozzi A; Picconi B; Calabresi P
    J Alzheimers Dis; 2010; 20 Suppl 2():S369-79. PubMed ID: 20463396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity and neuroinflammation.
    Shastri A; Bonifati DM; Kishore U
    Mediators Inflamm; 2013; 2013():342931. PubMed ID: 23843682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial control of immunity: beyond ATP.
    Mehta MM; Weinberg SE; Chandel NS
    Nat Rev Immunol; 2017 Oct; 17(10):608-620. PubMed ID: 28669986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question.
    Pistono C; Osera C; Boiocchi C; Mallucci G; Cuccia M; Bergamaschi R; Pascale A
    Pharmacol Res; 2017 Jun; 120():279-293. PubMed ID: 28396093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on disease-modifying therapies for multiple sclerosis.
    Vargas DL; Tyor WR
    J Investig Med; 2017 Jun; 65(5):883-891. PubMed ID: 28130412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Let's make microglia great again in neurodegenerative disorders.
    Guillot-Sestier MV; Town T
    J Neural Transm (Vienna); 2018 May; 125(5):751-770. PubMed ID: 29027011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria at the interface between neurodegeneration and neuroinflammation.
    Bader V; Winklhofer KF
    Semin Cell Dev Biol; 2020 Mar; 99():163-171. PubMed ID: 31154011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The central role of mitochondria in axonal degeneration in multiple sclerosis.
    Campbell GR; Worrall JT; Mahad DJ
    Mult Scler; 2014 Dec; 20(14):1806-13. PubMed ID: 25122475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usage of Multiparameter Flow Cytometry to Study Microglia and Macrophage Heterogeneity in the Central Nervous System During Neuroinflammation and Neurodegeneration.
    Dukhinova M; Kopeikina E; Ponomarev ED
    Methods Mol Biol; 2018; 1745():167-177. PubMed ID: 29476469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
    Giunti D; Parodi B; Cordano C; Uccelli A; Kerlero de Rosbo N
    Immunology; 2014 Mar; 141(3):328-39. PubMed ID: 24116890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.